These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects. Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Pitchot W; Hansenne M; Pinto E; Reggers J; Fuchs S; Ansseau M Biol Psychiatry; 2005 Dec; 58(11):854-8. PubMed ID: 16139805 [TBL] [Abstract][Full Text] [Related]
8. The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pitchot W; Ansseau M; Gonzalez Moreno A; Lembreghts M; Hansenne M; Wauthy J; Reel C; Jammaer R; Papart P; Sulon J Pharmacopsychiatry; 1995 Oct; 28 Suppl 2():91-2. PubMed ID: 8614706 [TBL] [Abstract][Full Text] [Related]
9. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. Pitchot W; Wauthy J; Legros JJ; Ansseau M Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031 [TBL] [Abstract][Full Text] [Related]
10. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Leone M; Attanasio A; Croci D; Ferraris A; D'Amico D; Grazzi L; Nespolo A; Bussone G Neuroreport; 1998 Aug; 9(11):2605-8. PubMed ID: 9721941 [TBL] [Abstract][Full Text] [Related]
11. Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Seletti B; Benkelfat C; Blier P; Annable L; Gilbert F; de Montigny C Neuropsychopharmacology; 1995 Oct; 13(2):93-104. PubMed ID: 8597527 [TBL] [Abstract][Full Text] [Related]
12. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878 [TBL] [Abstract][Full Text] [Related]
13. Central 5-HT receptor hypersensitivity in migraine without aura. Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577 [TBL] [Abstract][Full Text] [Related]
14. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics. Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256 [TBL] [Abstract][Full Text] [Related]
15. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150 [TBL] [Abstract][Full Text] [Related]
16. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Underwood MD; Mann JJ; Arango V Alcohol Clin Exp Res; 2004 May; 28(5 Suppl):57S-69S. PubMed ID: 15166637 [TBL] [Abstract][Full Text] [Related]
17. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Lejeune F; Millan MJ Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787 [TBL] [Abstract][Full Text] [Related]
18. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine responses to serotonergic agents in alcoholics. Lee MA; Meltzer HY Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196 [TBL] [Abstract][Full Text] [Related]
20. The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. Groenink L; Van der Gugten J; Verdouw PM; Maes RA; Olivier B Eur J Pharmacol; 1995 Jul; 280(2):185-93. PubMed ID: 7589185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]